KRONOX NSE filing

Kronox Lab Sciences Holds 17th AGM on Sep 16, 2026; Dividend Declared

The RealCase readLow impact Neutral

Kronox Lab Sciences held its 17th AGM on September 16, 2026. The company declared a final dividend of ₹0.50 per equity share for FY 2025-26. The audited financial statements for FY 2025-26 were adopted. Voting results will be announced by September 18, 2026.

Why it matters

The announcement pertains to a routine AGM and dividend declaration, which is a standard corporate action and is unlikely to have a significant impact on the company's stock price.

The market read

The announcement is a routine disclosure of the AGM proceedings and dividend declaration, which is a standard corporate event.

Kronox Lab Sciences Limited convened its 17th Annual General Meeting (AGM) on Wednesday, September 16, 2026, commencing at 11:00 AM IST via Video Conferencing (VC)/Other Audio Visual Means (OAVM). The meeting, which concluded at 12:45 PM, was presided over by Chairman & Managing Director, Mr. Jogindersingh Jaswal.

The AGM transacted several key businesses including the adoption of audited financial statements for the financial year ended March 31, 2026, along with the Board of Directors' and Auditors' reports. A final dividend of ₹0.50 per equity share for the financial year 2025-26 was declared.

Additionally, the meeting addressed the reappointment of Mr. Jogindersingh Jaswal, who retired by rotation and offered himself for reappointment, and ratified the remuneration payable to the Cost Auditors for the financial year 2026-27. Shareholders who had registered as speakers were given an opportunity to ask questions, which were addressed by the management.

The voting results of the AGM are scheduled to be declared and disseminated to the stock exchanges on or before September 18, 2026, and will also be published on the company's website.

Filing to action

What to do with a filing like this

Kronox Lab Sciences Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Kronox Lab Sciences Limited. Read the original for the full detail.

View original filing